New research reveals that patients who stop using blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover shed pounds at a significantly accelerated pace than those who halt traditional lifestyle plans.
Research printed in a leading health publication demonstrates that while overweight people frequently drop a large proportion of their total mass while undergoing treatment, the mass is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"People purchasing these drugs must be aware of the potential of quick rebound weight gain when the treatment is stopped," warns researcher Dr. Susan Jebb.
This pace of regain means a reversion to pre-treatment mass in about a year and a half.
Analyzing Approaches
The study, which reviewed 37 of trials involving thousands of patients, compared the effects of GLP-1 agonists with older methods.
Scientists emphasize that individuals who shed pounds through lifestyle changes alone generally experience a more gradual weight regain—perhaps 0.1 kg a month—once they finish.
The Reason for the Quick Rebound
Nutrition scientists propose the mechanism of the drugs is key to understanding the heightened weight return.
The injections copy a body's own chemical called GLP-1, which moderates hunger.
"Artificially providing GLP-1 concentrations several times higher than normal could lead to the system to generate a reduced amount of its own natural hormone, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert.
"Discontinuation of this medication means appetite is no longer kept in check, making excessive eating far more likely."
A Lifelong Issue?
Medical guidelines suggest the jabs for people with obesity-related health risks, accompanied by prescribed lifestyle changes.
Many experts contend that, due to the likelihood of weight regain, the therapy might need to be ongoing.
This perspective is reinforced by pharmaceutical companies, who note that the findings "underscore the chronic character of excess weight," comparing it to managing diseases like diabetes.
User Testimonies
Individuals who have discontinued the jabs explain a intense resurgence of hunger.
"It felt as if a switch activating and I was suddenly extremely hungry," described one woman.
The struggle is exacerbated if individuals have not adopted sustainable dietary or behavioural modifications during treatment.
Growing Use
Recent estimates indicate that millions of people in the UK have used these injections in the past year, with interest continuing to grow.
- Use is higher among women than males.
- The middle-aged age group shows the highest level of interest.
- A large proportion access the drugs through private prescriptions rather than public health services.
Finally, clinicians emphasize that while the jabs are potent agents for weight loss, they are not a standalone fix and long-term success likely depends on ongoing lifestyle management.
